RATIONALE: IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose (α-gal) are common in the southeastern United States. These antibodies, which are induced by ectoparasitic ticks, can give rise to positive skin tests or serum assays with cat extract. OBJECTIVES: To evaluate the relationship between IgE antibodies to α-gal and asthma, and compare this with the relationship between asthma and IgE antibodies to Fel d 1 and other protein allergens. METHODS: Patients being investigated for recurrent anaphylaxis, angioedema, or acute urticaria underwent spirometry, exhaled nitric oxide, questionnaires, and serum IgE antibody assays. The results were compared with control subjects and cohorts from the emergency department in Virginia (n = 130), northern Sweden (n = 963), and rural Kenya (n = 131). MEASUREMENTS AND MAIN RESULTS: Patients in Virginia with high-titer IgE antibodies to α-gal had normal lung function, low levels of exhaled nitric oxide, and low prevalence of asthma symptoms. Among patients in the emergency department and children in Kenya, there was no association between IgE antibodies to α-gal and asthma (odds ratios, 1.04 and 0.75, respectively). In Sweden, IgE antibodies to cat were closely correlated with IgE antibodies to Fel d 1 (r = 0.83) and to asthma (P < 0.001). CONCLUSIONS: These results provide a model of an ectoparasite-induced specific IgE response that can increase total serum IgE without creating a risk for asthma, and further evidence that the main allergens that are causally related to asthma are those that are inhaled.
RATIONALE: IgE antibodies to the mammalianoligosaccharidegalactose-α-1,3-galactose (α-gal) are common in the southeastern United States. These antibodies, which are induced by ectoparasitic ticks, can give rise to positive skin tests or serum assays with cat extract. OBJECTIVES: To evaluate the relationship between IgE antibodies to α-gal and asthma, and compare this with the relationship between asthma and IgE antibodies to Fel d 1 and other protein allergens. METHODS:Patients being investigated for recurrent anaphylaxis, angioedema, or acute urticaria underwent spirometry, exhaled nitric oxide, questionnaires, and serum IgE antibody assays. The results were compared with control subjects and cohorts from the emergency department in Virginia (n = 130), northern Sweden (n = 963), and rural Kenya (n = 131). MEASUREMENTS AND MAIN RESULTS:Patients in Virginia with high-titer IgE antibodies to α-gal had normal lung function, low levels of exhaled nitric oxide, and low prevalence of asthma symptoms. Among patients in the emergency department and children in Kenya, there was no association between IgE antibodies to α-gal and asthma (odds ratios, 1.04 and 0.75, respectively). In Sweden, IgE antibodies to cat were closely correlated with IgE antibodies to Fel d 1 (r = 0.83) and to asthma (P < 0.001). CONCLUSIONS: These results provide a model of an ectoparasite-induced specific IgE response that can increase total serum IgE without creating a risk for asthma, and further evidence that the main allergens that are causally related to asthma are those that are inhaled.
Authors: A Bjerg-Bäcklund; A B Bäcklund; M S Perzanowski; T Platts-Mills; T Sandström; B Lundbäck; E Rönmark Journal: Allergy Date: 2006-05 Impact factor: 13.146
Authors: Elizabeth A Erwin; Eva Rönmark; Kristin Wickens; Matthew S Perzanowski; David Barry; Bo Lundbäck; Julian Crane; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Date: 2007-02 Impact factor: 10.793
Authors: Scott P Commins; Hayley R James; Libby A Kelly; Shawna L Pochan; Lisa J Workman; Matthew S Perzanowski; Katherine M Kocan; John V Fahy; Lucy W Nganga; Eva Ronmark; Philip J Cooper; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Date: 2011-03-31 Impact factor: 10.793
Authors: Miriam F Moffatt; Ivo G Gut; Florence Demenais; David P Strachan; Emmanuelle Bouzigon; Simon Heath; Erika von Mutius; Martin Farrall; Mark Lathrop; William O C M Cookson Journal: N Engl J Med Date: 2010-09-23 Impact factor: 91.245
Authors: W Stevens; E Addo-Yobo; J Roper; A Woodcock; H James; T Platts-Mills; A Custovic Journal: Clin Exp Allergy Date: 2011-08-02 Impact factor: 5.018
Authors: Thomas A E Platts-Mills; Alexander J Schuyler; Anubha Tripathi; Scott P Commins Journal: Immunol Allergy Clin North Am Date: 2015-03-06 Impact factor: 3.479
Authors: Jean-Luc Malo; Susan M Tarlo; Joaquin Sastre; James Martin; Mohamed F Jeebhay; Nicole Le Moual; Dick Heederik; Thomas Platts-Mills; Paul D Blanc; Olivier Vandenplas; Gianna Moscato; Frédéric de Blay; André Cartier Journal: Ann Am Thorac Soc Date: 2015-07
Authors: Jeffrey M Wilson; Alexander J Schuyler; Lisa Workman; Monica Gupta; Hayley R James; Jonathon Posthumus; Emily C McGowan; Scott P Commins; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Pract Date: 2019-03-30
Authors: Thomas A E Platts-Mills; Alexander J Schuyler; Elizabeth A Erwin; Scott P Commins; Judith A Woodfolk Journal: J Allergy Clin Immunol Date: 2016-04-27 Impact factor: 10.793